March 3, 2026 · Form 4 insider transaction
Horn Howard sold 1,635 shares of Ultragenyx Pharmaceutical Inc. at $22.40 per share, a transaction worth $36.6K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.